Wellington Management Group LLP Otonomy, Inc. Transaction History

Wellington Management Group LLP

  • $548 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.06 - $2.67 $1.59 Million - $2.06 Million
-771,768 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$2.49 - $6.23 $87,854 - $219,813
35,283 Added 4.79%
771,768 $1.97 Million
Q4 2020

Feb 12, 2021
BUY
$3.48 - $6.47 $2.56 Million - $4.77 Million
736,485 New
736,485 $4.77 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email